Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients
Study Type: Treatment
Phase: III
NCTID: NCT05838716
Principal Investigator:
Elizabeth Wulff-Burchfield
Randomized Phase II Trial of Niraparib with Standard Combination Radiotherapy and Androgen Deprivation Therapy ADT in High Risk Prostate Cancer with Initial Phase I NADIR Randomized Phase II Trial of Niraparib with Standard Combination Androgen Deprivation Therapy ADT and Radiotherapy in High Risk Prostate Cancer with Initial Phase I
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study Of Darolutamide Plus Androgen Deprivation Therapy ADT Compared To Placebo Plus ADT In Patients With High-Risk Biochemical Recurrence BCR Of Prostate Cancer
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer after Radical Prostatectomy INNOVATE INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
Phase III Randomized Trial of Standard Systemic Therapy SST versus Standard Systemic Therapy Plus Definitive Treatment Surgery or Radiation of the Primary Tumor in Metastatic Prostate Cancer
Parallel Phase III Randomized Trials Of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification And Intensification Clinical Trial Evaluation Guidance
Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
Study Type: Health Services
Phase: III
NCTID: NCT03860961
Principal Investigator:
Ronald Chen
A Phase III, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA IT PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection
Pilot of Osanetant to Reduce Severity of Hot Flashes in Men with Adenocarcinoma of the Prostate POSH-MAP
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT05647447
Principal Investigator:
Elizabeth Wulff-Burchfield
PREcision DIagnostics in Prostate Cancer Treatment PREDICT
Study Type: Treatment
Phase: II
NCTID: NCT06632977
Principal Investigator:
Elizabeth Wulff-Burchfield